Related references
Note: Only part of the references are listed.LONG-TERM EFFECTS OF A BERBERINE BASED NUTRACEUTICAL ON BODY WEIGHT AND INSULIN-SENSITIVITY IN NON DIABETIC HYPERLIPIDAEMIC PATIENTS
A. Cicero et al.
JOURNAL OF HYPERTENSION (2013)
A nutraceutical combination improves insulin sensitivity in patients with metabolic syndrome
Flora Affuso et al.
WORLD JOURNAL OF CARDIOLOGY (2012)
IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030
David R. Whiting et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2011)
Berberine ameliorates hyperglycemia in alloxan-induced diabetic C57BL/6 mice through activation of Akt signaling pathway
Xi Xie et al.
ENDOCRINE JOURNAL (2011)
Berberine reducing insulin resistance by up-regulating IRS-2 mRNA expression in nonalcoholic fatty liver disease (NAFLD) rat liver
Lian-Jun Xing et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Meta-analysis of the effect of herbal supplement on glycemic control in type 2 diabetes
Naeti Suksomboon et al.
JOURNAL OF ETHNOPHARMACOLOGY (2011)
Dose-response of berberine on hepatic cytochromes P450 mRNA expression and activities in mice
Ying Guo et al.
JOURNAL OF ETHNOPHARMACOLOGY (2011)
Modulating gut microbiota as an anti-diabetic mechanism of berberine
Junling Han et al.
MEDICAL SCIENCE MONITOR (2011)
Berberine Improves Glucose Metabolism in Diabetic Rats by Inhibition of Hepatic Gluconeogenesis
Xuan Xia et al.
PLOS ONE (2011)
Effects and Action Mechanisms of Berberine and Rhizoma coptidis on Gut Microbes and Obesity in High-Fat Diet-Fed C57BL/6J Mice
Weidong Xie et al.
PLOS ONE (2011)
Anti-cancer natural products isolated from chinese medicinal herbs
Wen Tan et al.
CHINESE MEDICINE (2011)
被撤回的出版物: Berberine ameliorates renal injury in diabetic C57BL/6 mice: Involvement of suppression of SphK-S1P signaling pathway (Retracted article. See vol. 742, 2023)
Tian Lan et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2010)
Berberine suppresses intestinal disaccharidases with beneficial metabolic effects in diabetic states, evidences from in vivo and in vitro study
Li Liu et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2010)
Berberine-induced activation of 5′-adenosine monophosphate-activated protein kinase and glucose transport in rat skeletal muscles
Xiao Ma et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2010)
Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression
Hao Zhang et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2010)
Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study
F. Affuso et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2010)
Effect of traditional Chinese medicine berberine on type 2 diabetes based on comprehensive metabonomics
Yan Gu et al.
TALANTA (2010)
Targeting metabolic syndrome: Candidate natural agents
Xuan Xia et al.
JOURNAL OF DIABETES (2010)
Berberine-Induced Upregulation of Circulating Endothelial Progenitor Cells Is Related to Nitric Oxide Production in Healthy Subjects
Ming-Guo Xu et al.
CARDIOLOGY (2009)
Limitations of statin monotherapy for the treatment of dyslipidemia: a projection based on the Canadian lipid study - observational
Martin Senecal et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Berberine-induced decline in circulating CD31+/CD42- microparticles is associated with improvement of endothelial function in humans
Jie-mei Wang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Protective effect of berberine on beta cells in streptozotocin- and high-carbohydrate/high-fat diet-induced diabetic rats
Jiyin Zhou et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Hepatocyte Nuclear Factor 1α Plays a Critical Role in PCSK9 Gene Transcription and Regulation by the Natural Hypocholesterolemic Compound Berberine
Hai Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Berberine promotes glucagon-like peptide-1 (7-36) amide secretion in streptozotocin-induced diabetic rats
Shou-Si Lu et al.
JOURNAL OF ENDOCRINOLOGY (2009)
Identification of mRNA binding proteins that regulate the stability of LDL receptor mRNA through AU-rich elements
Hai Li et al.
JOURNAL OF LIPID RESEARCH (2009)
Berberine, a natural lipid-lowering drug, exerts prothrombotic effects on vascular cells
Erik W. Holy et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2009)
Berberine reduces fibronectin and collagen accumulation in rat glomerular mesangial cells cultured under high glucose condition
Weihua Liu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2009)
Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin. receptor expression
Wei-Jia Kong et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2009)
Berberine improves glucose metabolism through induction of glycolysis
Jun Yin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Berberine decreases PCSK9 expression in HepG2 cells
Jamie Cameron et al.
ATHEROSCLEROSIS (2008)
Chronic effects of berberine on blood, liver glucolipid metabolism and liver PPARs expression in diabetic hyperlipidemic rats
Ji Yin Zhou et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2008)
Reduction of blood lipid by berberine in hyperlipidemic patients with chronic hepatitis or liver cirrhosis
Wei Zhao et al.
BIOMEDICINE & PHARMACOTHERAPY (2008)
Berberine modifies cysteine 179 of IκBα kinase, suppresses nuclear factor-κB-regulated antiapoptotic gene products, and potentiates apoptosis
Manoj K. Pandey et al.
CANCER RESEARCH (2008)
Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: A mechanism for the action of berberine to activate AMP-Activated protein kinase and improve insulin action
Nigel Turner et al.
DIABETES (2008)
Berberine acutely inhibits insulin secretion from beta-cells through 3 ',5 '-cyclic adenosine 5 '-monophosphate signaling pathway
Libin Zhou et al.
ENDOCRINOLOGY (2008)
Berberine inhibits platelet-derived growth factor-induced growth and migration partly through an AMPK-dependent pathway in vascular smooth muscle cells
Kae-Woei Liang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine
Yifei Zhang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Combination of simvastatin with berberine improves the lipid-lowering efficacy
Wei-Jia Kong et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2008)
Efficacy of berberine in patients with type 2 diabetes mellitus
Jun Yin et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2008)
Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine
Mohsen Imanshahidi et al.
PHYTOTHERAPY RESEARCH (2008)
Facilitating effects of berberine on rat pancreatic islets through modulating hepatic nuclear factor 4 alpha expression and glucokinase activity
Zhi-Quan Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Berberine reverses free-fatty-acid-induced insulin resistance in 3T3-L1 adipocytes through targeting IKKβ
Ping Yi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Traditional Chinese Medicine in Treatment of Metabolic Syndrome
Jun Yin et al.
Endocrine Metabolic & Immune Disorders-Drug Targets (2008)
An update on regional variation in cardiovascular mortality within Europe
Jacqueline Mueller-Nordhorn et al.
EUROPEAN HEART JOURNAL (2008)
Berberine-induced mobilization of circulating endothelial progenitor cells improves human small artery elasticity
M-G Xu et al.
JOURNAL OF HUMAN HYPERTENSION (2008)
Berberine-induced LDLR up-regulation involves JNK pathway
Seahyoung Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Berberine activates GLUT1-mediated glucose uptake in 3T3-L1 adipocytes
So Hui Kim et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2007)
Berberine stimulates glucose transport through a mechanism distinct from insulin
Libin Zhou et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2007)
Berberine reduces the expression of adipogenic enzymes and inflammatory molecules of 3T3-L1 adipocyte
Bong-Hyuk Choi et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2006)
Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK
Zhe Cheng et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2006)
Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARγ pathway
Cheng Huang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine
Jean-Marie Brusq et al.
JOURNAL OF LIPID RESEARCH (2006)
Berberine suppresses MEK/ERK-dependent Egr-1 signaling pathway and inhibits vascular smooth muscle cell regrowth after in vitro mechanical injury
KW Liang et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Roles of nitric oxide in protective effect of berberine in ethanol-induced gastric ulcer mice
LR Pan et al.
ACTA PHARMACOLOGICA SINICA (2005)
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
C Baigent et al.
LANCET (2005)
Extracellular signal-regulated kinase-dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine berberine
P Abidi et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Insulin sensitizing and insulinotropic action of berberine from Cortidis rhizoma
BS Ko et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2005)
The antihypertensive and vasodilator effects of aqueous extract from Berberis vulgaris fruit on hypertensive rats
Z Fatehi-Hassanabad et al.
PHYTOTHERAPY RESEARCH (2005)
Hepatobiliary excretion of berberine
PL Tsai et al.
DRUG METABOLISM AND DISPOSITION (2004)
Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins
WJ Kong et al.
NATURE MEDICINE (2004)
Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
XH Zeng et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Effect of berberine on catecholamine levels in rats with experimental cardiac hypertrophy
Y Hong et al.
LIFE SCIENCES (2003)
Effects of berberine on angiotensin-converting enzyme and NO/cGMP system in vessels
DG Kang et al.
VASCULAR PHARMACOLOGY (2002)
Effects of berberine on glucose metabolism in vitro
J Yin et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2002)
Inhibitory effect of berberine on tert-butyl hydroperoxide-induced oxidative damage in rat liver
JM Hwang et al.
ARCHIVES OF TOXICOLOGY (2002)
Effect of berberine on arachidonic acid metabolism in rabbit platelets and endothelial cells
CG Huang et al.
THROMBOSIS RESEARCH (2002)
Effect of berberine on regression of pressure-overload induced cardiac hypertrophy in rats
Y Hong et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2002)
Vasorelaxant and antiproliferative effects of berberine
WH Ko et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Share Paper
